Stay updated on Psilocybin Safety & Efficacy in TRD - Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy in TRD - Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy in TRD - Clinical Trial page
- Check5 days agoChange DetectedAn NIH sitewide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appeared, and the site revision changed from v3.7.1 to v3.7.2. The study page continues to display a 403 Forbidden error.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check33 days agoChange DetectedSeveral documents in the Study Documents section have been removed, including the Statistical Analysis Plan and the Study Protocol. This change reduces direct access to the study's methodological details and supporting materials on the page.SummaryDifference17%

- Check40 days agoChange DetectedThe page version was updated from v3.6.6 to v3.7.0, signaling a newer version of the study details page. This update likely involves behind-the-scenes improvements without altering the displayed study content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, signaling a small template/backend update. The displayed study details remain unchanged.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating an updated version of the study page template used on the ClinicalTrials.gov entry.SummaryDifference0.0%

Stay in the know with updates to Psilocybin Safety & Efficacy in TRD - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy in TRD - Clinical Trial page.